Treyfish
Moderator
Re: General Indo BF news
Re: General Indo BF news
On Sunday, 27/05/2007 17:42 WIB in October, Bibit Vaksin Flu Burung Strain Indonesia DiproduksiJakarta ? After through the clinical test the second stage, his plan the clinical test the third stage that is the trial to humankind, the bird flu vaccine strain Indonesia will be done this coming July.And was aimed at in October 2007 the vaccine has begun to be produced in the form of stock piling (the prospective vaccine).Health Minister Siti Fadilah Supari said, for the first stage his side produced approximately 20 million doses.However he admitted to not yet knowing how many values of the budget that was needed to produce this vaccine."Aimed at by us will produce 10% from the total Indonesian inhabitant, I did not yet know how many budgets that were needed."However that was certain we will only pay his raw material not was based on the market price, he said in Jakarta, on Sunday (27/5/2007).It was further that he stated, that the development of the vaccine that was done co-operated with Baxter Healthcare Switzerland -- one of the producer's companies of the vaccine that had an office the centre in the United States -- through several stages.That is by using the system down stream (the production system in the part lower-red).In this system of Indonesia in stages could carry out the transfer of technology in producing the bird flu vaccine.Meaning that when the Indonesian bird flu pandemic happening has had the system to produce the bird flu vaccine in a mass fashion.Menkes explained in the system down stream this, said he, eventually Baxter will produce the vaccine in the upstream part (the process of seedling cultivation and the cultivation of the vaccine), whereas the Indonesian government in this case PT Bio Farma will handle the lower process (filling).The process filling needed the process monitoring the quality (quality control) as well as used the special room available in PT Bio Farma.According to Menkes, with the production capacity stockpiling the vaccine totalling 3 million doses per the week, Baxter certainly met satisfied the requirement for the domestic vaccine.Totally the Indonesian inhabitants around 220 million souls, then was not possible for APBN to have the capacity to satisfy all the requirements.Nevertheless, must be given priority to by giving priority to areas endemi bird flu that at this time has infected 11 from from 33 provinces in Indonesia."Hopefully around September the clinical test humankind has been finished was carried out, so that in October stockpil has begun to be produced."If the country that had much certain money will make stockpiling in a large number, but because of considering the APBN capacity, we will determine the scale of the priority, he said.The head of the Penelitian Dan Pengembangan Kesehatan Body (Balitbangkes) the Department of Health, Triono Soendoro said that each entitled country carried out the co-operation with all the industries anywhere.MoU with Baxter that was signed last February, matched at this time still continued.At this time still the clinical test stage in the human test, will be begun early June, this year has been finished stock piling him.In the meantime, the Managing Director PT Biofarma, Marzuki Abdullah admitted to till at this time not yet having confirmation that his side will be involved in the production of the bird flu vaccine.As the producer's company of the domestic vaccine, said he, Biofarma has begun to prepare the laboratory BSL-3 (biosecurity level-3) with the budget around Rp 18 billion.According to him, if the prospective vaccine that was produced by Baxter in the form of down stream, then was no longer necessary used BSL-3.However if this prospective vaccine in the form of upstream, then BSL-3 absolute was needed."Till at this time we did not yet get confirmation that we will be involved in the production" of the "bird flu vaccine."However that was certain if we will be involved, then that must be prepared by the budget for the purchase of the feeling machine from Germany and as well as penelitan and the development, he said.He explained, for the purchase of the production machine of the Bosch make vaccine from this Germany was needed by the budget around Rp22 billion.Now the cost for the research and the development around Rp10 billion.The total budget that was needed for preparations for the production of the vaccine around Rp50 billion.His side admitted to trying to get this budget from the treasury of PT Biofarma personally, was increased with help from the Kesehatan Body of the World (WHO) for the development of this year vaccine of USD 2 million."Secara all equipment and the machine can be prepared by us as soon as possible."However that was not yet the training for local powers to memprpduksi this vaccine in a mass fashion.The transfer of this technology could be carried out by Baxter, or trainer other, he explained.:tiphat: http://www.okezone.com/index.php?option=com_content&task=view&id=23239&itemid=2</PRE>
Re: General Indo BF news
On Sunday, 27/05/2007 17:42 WIB in October, Bibit Vaksin Flu Burung Strain Indonesia DiproduksiJakarta ? After through the clinical test the second stage, his plan the clinical test the third stage that is the trial to humankind, the bird flu vaccine strain Indonesia will be done this coming July.And was aimed at in October 2007 the vaccine has begun to be produced in the form of stock piling (the prospective vaccine).Health Minister Siti Fadilah Supari said, for the first stage his side produced approximately 20 million doses.However he admitted to not yet knowing how many values of the budget that was needed to produce this vaccine."Aimed at by us will produce 10% from the total Indonesian inhabitant, I did not yet know how many budgets that were needed."However that was certain we will only pay his raw material not was based on the market price, he said in Jakarta, on Sunday (27/5/2007).It was further that he stated, that the development of the vaccine that was done co-operated with Baxter Healthcare Switzerland -- one of the producer's companies of the vaccine that had an office the centre in the United States -- through several stages.That is by using the system down stream (the production system in the part lower-red).In this system of Indonesia in stages could carry out the transfer of technology in producing the bird flu vaccine.Meaning that when the Indonesian bird flu pandemic happening has had the system to produce the bird flu vaccine in a mass fashion.Menkes explained in the system down stream this, said he, eventually Baxter will produce the vaccine in the upstream part (the process of seedling cultivation and the cultivation of the vaccine), whereas the Indonesian government in this case PT Bio Farma will handle the lower process (filling).The process filling needed the process monitoring the quality (quality control) as well as used the special room available in PT Bio Farma.According to Menkes, with the production capacity stockpiling the vaccine totalling 3 million doses per the week, Baxter certainly met satisfied the requirement for the domestic vaccine.Totally the Indonesian inhabitants around 220 million souls, then was not possible for APBN to have the capacity to satisfy all the requirements.Nevertheless, must be given priority to by giving priority to areas endemi bird flu that at this time has infected 11 from from 33 provinces in Indonesia."Hopefully around September the clinical test humankind has been finished was carried out, so that in October stockpil has begun to be produced."If the country that had much certain money will make stockpiling in a large number, but because of considering the APBN capacity, we will determine the scale of the priority, he said.The head of the Penelitian Dan Pengembangan Kesehatan Body (Balitbangkes) the Department of Health, Triono Soendoro said that each entitled country carried out the co-operation with all the industries anywhere.MoU with Baxter that was signed last February, matched at this time still continued.At this time still the clinical test stage in the human test, will be begun early June, this year has been finished stock piling him.In the meantime, the Managing Director PT Biofarma, Marzuki Abdullah admitted to till at this time not yet having confirmation that his side will be involved in the production of the bird flu vaccine.As the producer's company of the domestic vaccine, said he, Biofarma has begun to prepare the laboratory BSL-3 (biosecurity level-3) with the budget around Rp 18 billion.According to him, if the prospective vaccine that was produced by Baxter in the form of down stream, then was no longer necessary used BSL-3.However if this prospective vaccine in the form of upstream, then BSL-3 absolute was needed."Till at this time we did not yet get confirmation that we will be involved in the production" of the "bird flu vaccine."However that was certain if we will be involved, then that must be prepared by the budget for the purchase of the feeling machine from Germany and as well as penelitan and the development, he said.He explained, for the purchase of the production machine of the Bosch make vaccine from this Germany was needed by the budget around Rp22 billion.Now the cost for the research and the development around Rp10 billion.The total budget that was needed for preparations for the production of the vaccine around Rp50 billion.His side admitted to trying to get this budget from the treasury of PT Biofarma personally, was increased with help from the Kesehatan Body of the World (WHO) for the development of this year vaccine of USD 2 million."Secara all equipment and the machine can be prepared by us as soon as possible."However that was not yet the training for local powers to memprpduksi this vaccine in a mass fashion.The transfer of this technology could be carried out by Baxter, or trainer other, he explained.:tiphat: http://www.okezone.com/index.php?option=com_content&task=view&id=23239&itemid=2</PRE>